Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions

Nov.18.2024
Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Shenzhen police, in collaboration with the State Tobacco Monopoly Administration, successfully cracked a major case involving counterfeit ALIBARBAR vapes.

Statement:

On November 22, 2Firsts received a letter from Shenzhen Xiyue Intelligent Technology Manufacturing Co., Ltd. The letter stated that the products shown in the original and counterfeit comparison images in the article "ALIBARBAR Counterfeit Case," first published on sznews were not produced by the company. However, the vape production license number displayed in the images belongs to the company and is suspected of being misappropriated.

 

Since sznews has removed the images, 2Firsts has also deleted them. This statement is issued for clarification.


Shenzhen police and the State Tobacco Monopoly Administration seized tens of thousands of counterfeit ALIBARBAR vapes worth millions, cracking a major case and targeting illegal counterfeit sales, sznews reported on November 15.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Law enforcement in Shenzhen conducted simultaneous raids across multiple locations in one district, shutting down three counterfeit vape production and sales operations. The raids resulted in the seizure of tens of thousands of fake ALIBARBAR vapes, along with manufacturing equipment, raw materials, and packaging materials.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Scene of the crime | Image source: sznews

 

During interrogation, the suspects confessed to the crimes of producing and selling counterfeit vapes. They admitted to manufacturing large quantities of fake vapes for high profits and distributing them to overseas markets. The case is currently under further investigation.

 

Shenzhen Police Uncover Counterfeit ALIBARBAR Vape Case Worth Tens of Millions
Crime scene | Image source: sznews

 

Shenzhen police announced their commitment to cracking down on counterfeit production and sales, working closely with the State Tobacco Monopoly Administration and other authorities to protect consumer rights. 

 

They also advised consumers to buy vape products only from official channels, warning that using counterfeit products could lead to serious health risks.

Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait Tightens Tobacco and Nicotine Rules, Bans Under-21 Sales and Extends Public Smoking Restrictions to Vapes and Heated Tobacco
Kuwait has issued a comprehensive new regulatory framework covering tobacco, e-cigarettes, heated tobacco and other nicotine products. Ministerial Decision No. 237 of 2026, signed by Health Minister Ahmad Al-Awadhi, will take effect on January 1, 2027. The rules prohibit sales to people under 21 and ban sales through websites, apps, social media and delivery services. E-cigarettes and heated tobacco products will also be treated as smoking in public and enclosed places where smoking is prohibited. Nicotine pouches and other oral nicotine products not registered as medicines are banned.
Regulations
Aug.17 by 2Firsts Perspectives
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03